Navigator Medicines
PrivateLast Round
Series A
Aug 27, 2024
Est. Valuation
$154M
Total Funding Raised
$100M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Navigator Medicines is a biotechnology company that develops bispecific antibody therapies for the treatment of complex autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Navigator Medicines Comparables
Compare Navigator Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IMBiologics | 89% | |
| BioCryst Pharmaceuticals | 77% | |
| Apogee Therapeutics | 76% | |
Navigator Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 27, 2024 |
Navigator Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| Forbion | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
Grew 23% QoQ, from 22 to 27 employees.
- May 20, 2026
Monthly visitors increased 89% MoM.
Navigator Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Navigator Medicines's valuation, stock price, and market status.